Temporary impact on medical system and effectiveness of mitigation strategies after COVID-19 policy adjustment in China: a modeling study

Chitin Hon, Jingyi Liang, Ruihan Chen, Zhijie Lin, Yangqianxi Wang, Wei He, Ruibin Liu, Jiaxi Sun, Qianyin Li, Lixi Liang, Minyi Zhang, Zichen Chang, Yinqiu Guo, Wenting Zeng, Tie Liu, Arlindo L. OliveiraFrontiers in Public Health 2023 · DOI

Abstract

The Omicron epidemic followed the adjustment to COVID-19 policy overloading many local health systems across the country at the end of 2022. The combined effect of vaccination, antipyretic drug supply, triage treatment, and PHSMs could prevent overwhelming medical resources.

Introduction

In December 2022, China transitioned away from its long-standing "zero COVID" strategy, leading to a rapid surge in infections driven by the highly transmissible Omicron BA.5 variant. This shift presented a significant risk: a "tsunami" of cases that could potentially collapse the national healthcare infrastructure, particularly fever clinics and respiratory hospital beds.

This study, published in Frontiers in Public Health, quantifies the impact of this policy adjustment and evaluates the effectiveness of various mitigation strategies. By simulating different scenarios, researchers aimed to identify the most effective combination of interventions—including vaccines, non-pharmacological interventions (NPIs), and drug stockpiles—to protect the medical system from being overwhelmed.

Methodology

The researchers developed an age-specific stochastic compartmental model to project the epidemic's trajectory and its demand on healthcare resources.

Structure of the age-specific stochastic compartmental model used to simulate COVID-19 transmission and healthcare demand.

Key features of the model include:

  • Population Stratification: The population was divided into two age groups (<60 and ≥60 years) to account for age-related differences in disease severity and vaccination status.
  • Vaccine Dynamics: The model distinguished between homologous boosters (same vaccine type) and heterologous boosters (mixed vaccine platforms, such as mRNA or adenovirus-vector boosters).
  • Transmission Modeling: A generation-interval-based method was used to calculate the effective reproduction number ($R_t$). Transitions between states—Susceptible (S), Exposed (E), Asymptomatic (A), Symptomatic (I), Recovered (R), and Hospitalized (H)—were simulated using a stochastic chain binomial process.
  • Capacity Benchmarking: Projected demands were compared against national capacity benchmarks, such as 7.02 million daily fever clinic visits and 0.908 million respiratory admission beds.

Data Sources

The study utilized publicly available aggregated data:

  • Epidemiological Parameters: Characteristics of Omicron BA.5 (e.g., incubation period, $R_0$) were sourced from existing literature.
  • Healthcare Capacity: Data on hospitals, fever clinics, and beds were obtained from the National Health Commission (NHC) and the 2016 National Healthcare Services and Quality Safety Report.
  • Vaccination and Effectiveness: Vaccination rates as of December 2022 were sourced from official NHC reports, while vaccine effectiveness (VE) against infection and hospitalization was compiled from international real-world studies.

Results and Strategic Insights

The modeling revealed that without significant intervention, the post-reopening wave would have catastrophic impacts on the healthcare system.

The Baseline Projection

In a scenario without further mitigation, the wave was projected to cause approximately 1.1 billion infections, 398 million fever clinic visits, and 16.6 million hospitalizations. At the peak, fever clinic demand would reach 4.4 times the national capacity, while hospital bed demand would soar to 6.5 times the available resources.

The Power of "Synergy"

The study emphasizes that no single measure is sufficient to prevent system failure. Instead, a synergistic approach is required:

  • Heterologous Boosters: Increasing heterologous booster coverage for the elderly to over 90% was identified as a critical measure, potentially reducing hospitalizations by 67–82%.
  • Antipyretic Drug Supply: High personal drug reserves (70% of the population) could act as a vital triage tool, reducing emergency department pressure by up to 90% for younger populations as fewer people with mild symptoms seek hospital care.
  • Capacity Expansion: Only by combining these mitigations with a 1.5x increase in medical resource capacity could the system remain functional during the peak.

Discussion and Limitations

While the study provides a roadmap for healthcare planning, the authors acknowledge several limitations. The lack of real-time infection data following the cessation of mass testing required inferring $R_t$ from NPI strength. Additionally, the model assumed constant vaccine effectiveness over the 120-day period, not accounting for the natural waning of immunity.

Future research should address the long-term immunogenicity of boosters and the potential impact of new viral mutations on healthcare resource requirements. Ultimately, the study underscores that while the initial Omicron wave was destined to challenge the system, strategic preparation and combined interventions can significantly flatten the curve and protect public health.

Summary updated

Abstract

The Omicron epidemic followed the adjustment to COVID-19 policy overloading many local health systems across the country at the end of 2022. The combined effect of vaccination, antipyretic drug supply, triage treatment, and PHSMs could prevent overwhelming medical resources.
BibTeX
@inproceedings{hon2023temporary,
  author = {Chitin Hon and Jingyi Liang and Ruihan Chen and Zhijie Lin and Yangqianxi Wang and Wei He and Ruibin Liu and Jiaxi Sun and Qianyin Li and Lixi Liang and Minyi Zhang and Zichen Chang and Yinqiu Guo and Wenting Zeng and Tie Liu and Arlindo L. Oliveira},
  title = {{Temporary impact on medical system and effectiveness of mitigation strategies after COVID-19 policy adjustment in China: a modeling study}},
  booktitle = {Frontiers in Public Health},
  year = {2023},
  doi = {10.3389/fpubh.2023.1259084},
}
Figure